🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 14% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Capsule(s) Serving Size
Botanical Product Type
14% Evidence Coverage

Supplement Facts — Evidence Check

240 mg
📊 Market median: 142.5mg (70 products)
Median 142.5mg This product: 240mg
Cascara Sagrada
150 mg
30 mg
📊 Market median: 420.0mg (127 products) 📚 1 studies (Tier A: 0, B: 1)
This product: 30mg
Juniper
8 mg
Rhubarb
8 mg
Gentian
8 mg
Buchu (Barosma betulina) leaf extract 4:1
1 mg

Other Ingredients

Corn Starch Magnesium Stearate Silicon Dioxide Sodium Bicarbonate oil of peppermint Pharmaceutical Glaze

Label Claims — Verification

All Other
All Other (100% of products) Structure/Function (87% of products) Nutrient (5% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Recommended Use: For a laxative effect. Recommended Dose (Adults): Take 2 tablets daily at bedtime. Promotes bowl movement in six to twelve hours. Do not use for more than a week at a time unless advised by a health care practitioner.

⚠️ Warnings & Precautions

Reduce dose or discontinue use if abdominal cramps, spasms and/or pain occur.

Risk Information: Do not use if pregnant or breastfeeding. Do not use if you have impaired kidney or liver functions, high blood pressure, heart disease or are taking heart medications or thiazide diuretics, corticosteroids, licorice root or other drugs that may aggravate electrolyte imbalance.

Do not use if you are a male with decreased libido. Do not use in the presence of abdominal pain, nausea, fever, vomiting, hemorrhoids or other symptoms of appendicitis or inflamed bowel or if you have a chronic gastrointestinal disorder. Over use or extended use may cause dependence for bowel function. Do not take any type of laxative for more than one week, unless your health care practitioner has ordered a special schedule for you.

Do not take within two hours of a medication. Consult a health care practitioner prior to use if you have diabetes, hypokalemia, or are taking hormonal therapies, diuretics, potassium depleting agents, or MAO inhibitors. Discontinue use if hypersensitivity occurs.

KEEP OUT OF REACH OF CHILDREN.

DO NOT USE IF SEAL UNDER CAP IS BROKEN.

Additional Information

STORE IN A COOL, DRY PLACE.

{Tablet} Actual Size

400484.01-04

SunOpta A healthy products company

A Proud Canadian Company

UPC CODE TO BE: 0 63047 05894 6

Product Details

DSLD Entry Date 2013-05-24
Product Type Botanical
Form Tablet or Pill
DSLD ID 21714
Data Updated 2026-04-11

Research Evidence

14 Research Sources
37 Avg Quality Score
8 Rct
4 Other
1 Meta Analysis
1 Narrative Review
C The Efficacy of Senna Bowel Preparation for Colonoscopy: A Systematic Review and Meta-analysis
Meta Analysis Gastroenterology nursing : the official journal of the Society of Gastroenterology Nurses and Associates
C Pre-administration of super-low volume polyethylene glycol is as effective as senna laxative as bowel preparation for colonoscopy: a randomized controlled phase 2 trial
Rct Surgical endoscopy 2022
C Polyethylene glycol versus split high-dose senna for bowel preparation: A comparative prospective randomized study
Rct Journal of gastroenterology and hepatology 2020
C Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination
Rct BMJ (Clinical research ed.) 1993
C Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial
Rct The American journal of gastroenterology 2021
C Polyethylene glycol powder solution versus senna for bowel preparation for colonoscopy in children
Rct Journal of pediatric gastroenterology and nutrition 2013
C Effectiveness of senna vs polyethylene glycol as laxative therapy in children with constipation related to anorectal malformation
Rct Journal of pediatric surgery 2017
D Standardized senna in the management of constipation in the puerperium: A clinical trial
Rct South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 1980
D Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients
Rct Pharmacology 1993
D Assessing product adulteration in natural health products for laxative yielding plants, Cassia, Senna, and Chamaecrista, in Southern India using DNA barcoding
Other International journal of legal medicine 2015
View all evidence for Senna →

Compare Similar Products

View all Senna products →